chloroquine diphosphate has been researched along with hydroxychloroquine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 7 (50.00) | 2.80 |
Authors | Studies |
---|---|
Parke, AL | 1 |
Sharma, OP; Verdegem, TD | 1 |
Burde, RM; Drews, RC; Hart, WM; Johnston, GP | 1 |
HARRISON, JW; SCHERBEL, AL; SCHUCHTER, SL | 1 |
Gol'dshteĭn, VD; Ivantsova, LN | 1 |
Altmeyer, P; Gaifullina, R; Gambichler, T; Kirschke, J; Kreuter, A; Tigges, C | 1 |
Francis, PJ; Michaelides, M; Stover, NB; Weleber, RG | 1 |
Bradley, SM; Fihn, SD; Perencevich, E | 1 |
Camci, ED; Davis, SN; Raible, DW; Rubel, EW; Simon, JA; Wu, P | 1 |
Ilunga, CK; Kongo, RM; Limbole, EB; Massolo, JM; Matangila, JR; Muyembe, BM; Mvwala, RK; Ngoy, CD; Ntalaja, JM; Nyembu, RK; Sakobo, TM; Telo, GM | 1 |
Ehrlich, H; Elkbuli, A | 1 |
Abayomi, A; Abdur-Razzaq, H; Anya, SE; Erinoso, OA; Ezechi, O; Kuyinu, Y; Ojo, O; Ola, B; Osibogun, A; Wright, K; Zamba, E | 1 |
Barbosa, LA; Enes, KP; Rocha, GM; Santos, HBD; Silva, IF; Thomé, RG; Varotti, FP | 1 |
Abiola, A; Adeyemo, WL; Agabi, OP; Aina, OO; Ajibaye, O; Akase, IE; Akinbode, GO; Akintan, PE; Amoo, OS; Audu, RA; Bamidele, TA; Bode, C; Busari, AA; David, AN; Esezobor, C; Ezechi, OC; Fadipe, B; Ima-Edomwonyi, E; James, AB; Musa, AZ; Nmadu, N; Okoyenta, CO; Okwuraiwe, AP; Oladele, DA; Olakiigbe, AK; Olopade, OB; Osuolale, KA; Otrofanowei, E; Raheem, TY; Salako, AO; Salako, BL; Tade, T | 1 |
2 trial(s) available for chloroquine diphosphate and hydroxychloroquine
Article | Year |
---|---|
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomi
Topics: Chloroquine; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Multicenter Studies as Topic; Nigeria; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2 | 2021 |
Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.
Topics: Adult; Chloroquine; COVID-19; Humans; Hydroxychloroquine; Middle Aged; Nigeria; SARS-CoV-2; Treatment Outcome | 2023 |
12 other study(ies) available for chloroquine diphosphate and hydroxychloroquine
Article | Year |
---|---|
Antimalarial drugs, systemic lupus erythematosus and pregnancy.
Topics: Abortion, Spontaneous; Antimalarials; Chloroquine; Female; Fetal Death; Humans; Hydroxychloroquine; Infant, Newborn; Infant, Premature; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications | 1988 |
Cutaneous ulcers in sarcoidosis.
Topics: Adult; Chloroquine; Female; Humans; Hydroxychloroquine; Middle Aged; Prednisone; Sarcoidosis; Skin; Skin Ulcer | 1987 |
Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
Topics: Adult; Arthritis, Rheumatoid; Chloroquine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Visual Acuity; Visual Field Tests; Visual Fields | 1984 |
Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine | 1957 |
[Long-term results of treatment and prediction in patients with sarcoidosis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Indomethacin; Male; Middle Aged; Prospective Studies; Sarcoidosis, Pulmonary; Severity of Illness Index; Time Factors | 2006 |
Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
Topics: Adult; Aged; Antimalarials; Chloroquine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Smoking; Treatment Outcome | 2009 |
Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Chloroquine; Disease Progression; Drug Therapy, Combination; Electroretinography; Female; Fluorescein Angiography; Humans; Hydroxychloroquine; Middle Aged; Retina; Retinal Diseases; Risk Factors; Tomography, Optical Coherence; Vision Disorders; Visual Field Tests; Visual Fields | 2011 |
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
Topics: Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus | 2020 |
Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity.
Topics: Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Chloroquine; Hair Cells, Auditory; Hydroxychloroquine; Larva; Lateral Line System; Mice; Models, Animal; Ototoxicity; Zebrafish | 2020 |
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
Topics: Adult; Aged; Blood Coagulation; Chloroquine; Coinfection; Comorbidity; Cough; COVID-19; COVID-19 Drug Treatment; Democratic Republic of the Congo; Female; Fever; Hospitalization; Hospitals, Public; Humans; Hydroxychloroquine; Inflammation; Liver Function Tests; Malaria; Male; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors; Social Class; Tachycardia | 2020 |
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
Topics: Angiotensin-Converting Enzyme 2; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Cardiovascular Diseases; Chloroquine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Humans; Hydroxychloroquine; Long QT Syndrome; Myocytes, Cardiac; Receptors, Coronavirus; SARS-CoV-2; Torsades de Pointes | 2021 |
Toxicological effects of hydroxychloroquine sulfate and chloroquine diphosphate substances on the early-life stages of fish in the COVID-19 pandemic context.
Topics: Animals; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Larva; Pandemics; Zebrafish | 2023 |